Medical Diagnositic

CEFALY to Showcase Migraine Relief Device at ACOG 2025

Innovative Neuromodulation Technology Offers Non-Drug Option for Migraine Sufferers, Including Pregnant Women...

OmniAb Launches xPloration® Partner Access Program to Accelerate Antibody Discovery Collaborations

New initiative aims to provide early-stage biotech and academic partners with greater access to OmniAb’s antibody discovery technologies, supporting innovation and therapeutic development. ...

Covera Health Expands Radiology Centers of Excellence with Prostate MRI Integration

New addition boosts diagnostic accuracy in prostate cancer care, strengthening Covera’s imaging quality program across U.S. healthcare networks...

Geneseeq Launches Innovative Blood Test for Early Pancreatic Cancer Detection

New Liquid Biopsy Technology Offers Hope in Diagnosing One of the Deadliest Cancers at an Early Stage...

Lunit to Power Germany's Largest Private Radiology Network with AI Imaging

South Korea’s Lunit signs major deal to deploy its AI diagnostic software across RAD-x, enhancing radiology workflows in over 20 German locations....

Lipogems Completes ARISE I Clinical Trial for Knee Osteoarthritis

Final patient visit marks major milestone in FDA IDE study, advancing treatment options for patients not eligible for knee replacement....

Roche Launches PRO-C3 by Nordic Bioscience on cobas Analyzers

New Fibrosis Biomarker Enhances Diagnostic Capabilities for Chronic Liver Disease Across Global Labs...

Seegene Unveils CURECA™ System for Fully Automated PCR Testing

Innovative platform streamlines sample-to-result diagnostics, offering scalable, multiplexed solutions for global clinical laboratories....

InMode Secures Injunction to Halt Counterfeit Morpheus8 Sales

Court Blocks Unauthorized Distribution of InMode’s RF Microneedling Devices and Cartridges in Major IP Protection Win ...

Human Longevity, Inc. Enhances Cancer Prevention Program with Avantect® Test

Company adopts ClearNote Health's early detection tool to identify pancreatic cancer at stage I, aiming to improve outcomes for high-risk individuals....